Low skeletal muscle radiodensity is a risk factor for adjuvant chemotherapy discontinuation in colorectal cancer

被引：0
|
作者：
Keigo Yokoi
Akiko Watanabe
Kazuko Yokota
Keita Kojima
Toshimichi Tanaka
Ken Kojo
Hirohisa Miura
Takahiro Yamanashi
Takeo Sato
Keishi Yamashita
Yusuke Kumamoto
Naoki Hiki
Takeshi Naitoh
机构：
[1] Kitasato University School of Medicine,Department of Lower Gastrointestinal Surgery
[2] Kitasato University School of Medicine,Department of Clinical Skills Education, Research and Development Center for Medical Education
[3] Kitasato University School of Medicine,Division of Advanced Surgical Oncology, Research and Development Center for New Medical Frontiers
[4] Kitasato University School of Medicine,Department of General
[5] Kitasato University School of Medicine,Pediatric
来源：
International Journal of Clinical Oncology | 2024年 / 29卷
关键词：
SMR; Myosteatosis; Adjuvant chemotherapy; Continuation; Colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：276 / 285
页数：9
相关论文
共 50 条
  • [21] Low Skeletal Muscle Mass before Salvage-Line Chemotherapy Is a Poor Prognostic Factor in Patients with Refractory Metastatic Colorectal Cancer
    Miyamoto, Yuji
    Hiyoshi, Yukiharu
    Akiyama, Takahiko
    Kiyozumi, Yuki
    Eto, Kojiro
    Yohei, Nagai
    Iwagami, Shiro
    Baba, Yoshifumi
    Yoshida, Naoya
    Baba, Hideo
    DIGESTION, 2019, 99 (01) : 79 - 85
  • [22] Skeletal muscle gauge as a prognostic factor in patients with colorectal cancer
    Park, In Kyu
    Yang, Song Soo
    Chung, Eric
    Cho, Eun-Suk
    Lee, Hye Sun
    Shin, Su-Jin
    Im, Yeong Cheol
    Park, Eun Jung
    Baik, Seung Hyuk
    Lee, Kang Young
    Kang, Jeonghyun
    CANCER MEDICINE, 2021, 10 (23): : 8451 - 8461
  • [23] Lymph Node Ratio as a Risk Factor for Recurrence After Adjuvant Chemotherapy in Stage III Colorectal Cancer
    Ooki, Akira
    Akagi, Kiwamu
    Yatsuoka, Toshimasa
    Asayama, Masako
    Hara, Hiroki
    Nishimura, Yoji
    Katoh, Hiroshi
    Yamashita, Keishi
    Watanabe, Masahiko
    Yamaguchi, Kensei
    JOURNAL OF GASTROINTESTINAL SURGERY, 2017, 21 (05) : 867 - 878
  • [24] Lymph Node Ratio as a Risk Factor for Recurrence After Adjuvant Chemotherapy in Stage III Colorectal Cancer
    Akira Ooki
    Kiwamu Akagi
    Toshimasa Yatsuoka
    Masako Asayama
    Hiroki Hara
    Yoji Nishimura
    Hiroshi Katoh
    Keishi Yamashita
    Masahiko Watanabe
    Kensei Yamaguchi
    Journal of Gastrointestinal Surgery, 2017, 21 : 867 - 878
  • [25] Timing of adjuvant chemotherapy in colorectal cancer
    dos Santos, L. V.
    Faria, T. M. V.
    Lima, A. B. C.
    Abdalla, K. C.
    de Moraes, E. D.
    Cruz, M. R.
    Lima, J. P.
    COLORECTAL DISEASE, 2016, 18 (09) : 871 - 876
  • [26] Adjuvant chemotherapy for colorectal cancer.
    Demols A.
    Van Laethem J.L.
    Current Gastroenterology Reports, 2002, 4 (5) : 420 - 426
  • [27] ADJUVANT CHEMOTHERAPY FOR COLORECTAL-CANCER
    SCHMOLL, HJ
    CHIRURG, 1994, 65 (07): : 576 - 584
  • [28] ADJUVANT CHEMOTHERAPY IN COLORECTAL-CANCER
    WOLMARK, N
    CANADIAN JOURNAL OF SURGERY, 1985, 28 (05) : 416 - 419
  • [29] Optimising adjuvant chemotherapy for colorectal cancer
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (10): : 909 - 909
  • [30] CHEMOTHERAPY AS AN ADJUVANT TO SURGERY FOR COLORECTAL CANCER
    LAWRENCE, W
    TERZ, JJ
    HORSLEY, S
    DONALDSON, M
    LOVETT, WL
    BROWN, PW
    RUFFNER, BW
    REGELSON, W
    ANNALS OF SURGERY, 1975, 181 (05) : 616 - 623
12345